• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Merck, nearing completion of $1B Gardasil manufacturing push, eyes 2023 to double...

cafead

Administrator
Staff member
  • cafead   Apr 04, 2022 at 10:32: AM
via After running into HPV vaccine supply shortfalls throughout 2018 and 2019, Merck & Co. is now reaping the rewards of a more than $1 billion manufacturing investment.

The Gardasil maker has expanded human papillomavirus (HPV) vaccine capacity at its facility in Elkton, Virginia, to the tune of 120,000 square feet and 150 new jobs, Merck said Monday.

article source
 

<